Chlamydia pneumoniae survival in macrophages is regulated by free Ca2+ dependent reactive nitrogen and oxygen species

A A Azenabor1, A U Chaudhry

  • 1Department of Health Sciences, University of Wisconsin, Milwaukee, WI 53211, USA. aazenabo@uwm.edu

Abstract

Insights

Chlamydia pneumoniae survives better in macrophages lacking nitric oxide (NO), with increased reactive oxygen species (ROS). Calcium (Ca2+) and NO signaling influence bacterial growth and persistence, impacting chronic disease development.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Chlamydia pneumoniae infections can lead to chronic diseases despite macrophage immune defenses.
  • Understanding C. pneumoniae survival mechanisms within host macrophages is crucial for disease intervention.

Purpose of the Study:

  • To investigate the growth of C. pneumoniae in macrophages with varying nitric oxide (NO) levels.
  • To determine the roles of calcium (Ca2+), NO, and reactive oxygen species (ROS) in C. pneumoniae infection.

Main Methods:

  • Culturing RAW-264.7 macrophages with sufficient (NO+) and insufficient (NO-) nitric oxide.
  • Assessing C. pneumoniae growth and inclusion formation.
  • Measuring ROS, superoxide dismutase (SOD), and catalase activities.
  • Evaluating the effects of ascorbic acid, an NO synthase inhibitor, and glutathione.

Main Results:

  • RAW-264.7 NO(-) cells showed significantly higher C. pneumoniae growth, increased ROS, SOD, and catalase activity compared to NO(+) cells.
  • Ascorbic acid, an inducible nitric oxide synthase inhibitor, and glutathione enhanced Chlamydia inclusion formation.
  • Cytosolic Ca(2+) regulated bacterial growth, NO generation, and antioxidant enzyme activities in both cell types.

Conclusions:

  • Minimal Ca(2+) signaling, alongside NO and ROS release, modulates C. pneumoniae survival, persistence, and chronicity in macrophages.
  • These factors are critical for initiating diseases where C. pneumoniae is a suspected etiological agent.

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Immune Surveillance by NK Cells and Phagocytes01:27

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...